44 Baillie Gifford Alnylam Pharmaceuticals Trades
Baillie Gifford's position in Alnylam Pharmaceuticals is currently worth $994 Million. That's 0.76% of their equity portfolio (30th largest holding). The investor owns 5.26% of the outstanding Alnylam Pharmaceuticals stock. The first Alnylam Pharmaceuticals trade was made in Q1 2013. Since then Baillie Gifford bought shares 25 more times and sold shares on eighteen occasions. The stake costed the investor $621 Million, netting the investor a gain of 60% so far.
Avg closing price
Price range
Sold 4.9% shares (-344 Thousand shares)
Q1 2024
Avg closing price
$166.82
Price range
$146.51
-
$198.20
Sold 14.7% shares (-1.2 Million shares)
Q4 2023
Avg closing price
$170.34
Price range
$151.41
-
$196.57
Sold 2.7% shares (-229 Thousand shares)
Q3 2023
Avg closing price
$190.79
Price range
$170.77
-
$211.65
Sold 2.9% shares (-247 Thousand shares)
Q2 2023
Avg closing price
$198.26
Price range
$185.01
-
$212.05
Sold 8.2% shares (-769 Thousand shares)
Q1 2023
Avg closing price
$210.20
Price range
$182.66
-
$235.53
Sold 1.1% shares (-107 Thousand shares)
Q4 2022
Avg closing price
$213.29
Price range
$185.11
-
$241.31
Sold 4.6% shares (-454 Thousand shares)
Q3 2022
Avg closing price
$190.40
Price range
$138.54
-
$233.85
Sold 1.7% shares (-171 Thousand shares)
Q2 2022
Avg closing price
$141.87
Price range
$120.42
-
$169.29
Sold 4.5% shares (-477 Thousand shares)
Q1 2022
Avg closing price
$152.35
Price range
$127.18
-
$173.91
Increased shares by 1.9% (+201 Thousand shares)
Q4 2021
Avg closing price
$185.86
Price range
$159.56
-
$209.29
Increased shares by 1.9% (+191 Thousand shares)
Q3 2021
Avg closing price
$187.58
Price range
$169.75
-
$207.73
Increased shares by 1.5% (+150 Thousand shares)
Q2 2021
Avg closing price
$146.46
Price range
$128.63
-
$176.89
Increased shares by 10.3% (+943 Thousand shares)
Q1 2021
Avg closing price
$150.49
Price range
$126.83
-
$175.69
Increased shares by 2.7% (+241 Thousand shares)
Q4 2020
Avg closing price
$133.53
Price range
$122.97
-
$147.00
Increased shares by 2.8% (+243 Thousand shares)
Q3 2020
Avg closing price
$142.11
Price range
$121.19
-
$165.49
Increased shares by 2.8% (+237 Thousand shares)
Q2 2020
Avg closing price
$134.81
Price range
$104.21
-
$156.44
Increased shares by 2.7% (+225 Thousand shares)
Q1 2020
Avg closing price
$115.43
Price range
$93.12
-
$133.99
Sold 0.6% shares (-49.3 Thousand shares)
Q4 2019
Avg closing price
$99.70
Price range
$74.51
-
$124.23
Increased shares by 32.6% (+2.02 Million shares)
Q3 2019
Avg closing price
$79.11
Price range
$70.90
-
$87.82
Increased shares by 9.3% (+529 Thousand shares)
Q2 2019
Avg closing price
$76.72
Price range
$65.86
-
$92.79
